Red White & Blooms Brands, Inc. RWB RWBYF reported Tuesday its third-quarter financial results with revenue of CA$25.5 million ($18.8 million) up by 128% from CA$11.2 million in the same period of 2021, and down 7% from CA$27.4 million in the previous quarter.
“In Q3, we were able to continue to drive significant revenue, SG&A, and balance sheet improvements over 2021,” Colby De Zen, president, and director, stated. ”We continue to proactively rationalize SG&A spend while remaining focused on driving growth through the expansion of product offerings and geographic footprint utilizing our asset-light strategy and profitability by selectively expanding branded offerings in higher margin product categories. The third quarter also saw the company complete the largest debt restructuring in our history resulting in a marked improvement in near-term liquidity through the extension of loan maturities and new financing.”
Q3 Financial Highlights
-
Net loss amounted to CA$8,455,562.
-
Gross profit before fair value adjustments for biological assets was CA$9,672,086, a 65% increase from CA$5,339,460 in the same quarter of 2021 and a 102% increase from Gross profit before fair value adjustments for biological assets recorded in 2022-Q2.
-
Gross profit after fair value adjustments for biological assets was CA$8,208,447, a 20% increase when compared to CA$6,863,943 in gross profits for the same quarter in 2021 and a 140% increase from Gross profit after fair value adjustments for biological assets recorded in 2022-Q2.
-
Operating expenses totaled CA$9,964,922, a 56% decrease when compared to Operating expenses of CA$22,864,397 for the same period in 2021.
-
General and Administrative Expenses totaled CA$3,188,625 versus CA$11,920,136, a CA$8,731,511 or 73% decrease compared to the same period in 2021 and a 108% decrease from General and Administrative Expenses recorded in 2022-Q2.
-
Adjusted EBITDA for the quarter was positive CA$3,311,531.
Price Action
Red White & Bloom shares were trading flat at $0.049 per share at the time of writing Tuesday morning.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!